Abstract:Tumor is a most deadly killer of humans. The low therapeutic efficiency and significant side effects caused by antitumor drugs are the main problems for tumor treatment currently. The use of tumor targeting drug carrier can greatly improve the therapeutic effect and reduce the side effects of antitumor drugs. However, the complex microenvironment of tumor (such as tumor progression, the expression level of related enzymes, and precise location of tumor cells) and individual difference among cancer patients (like drug intake efficiency and drug tolerance) often lead to failure of standardized treatment modality. Therefore, to get a good knowledge of the multifarious microenvironment of tumor is important for realizing precise and personalized treatment. In order to meet these requirements, it is urgent to develop multifunctional drug carriers for tumor targeting, diagnosis, imaging, treatment and prognosis. Many kinds of strategies have been performed to meet the multifunctionality requirement of the drug carriers, such as nanotechnology, stimuli-responsive technology and so on. At the same time, many kinds of materials were developed, like organic polymer, inorganic luminescent platform, functional peptide. Among them, peptide has drawn much attention. As we know, peptide has been widely used in the construction of stimulus responsive drug delivery system because of its unique properties such as good biocompatibility, simple synthesis, versatility, high responsiveness in the organism and so on. Ideally, through the enhanced permeability and retention (EPR) effect or the active tumor targeting process, the drug delivery system with functional peptide could reach the tumor, and then the loaded drugs and varies of diagnosis signal were released under special stimulus of tumor microenvironment or exogenous stimulus. This specific stimulating response of the peptide based carrier can maximize the anticancer effect, reduce the side effects of anticancer drug and improve the accuracy of tumor diagnosis. This work briefly reviews the research progress in applications of different types of stimulus responsive peptides in tumor diagnosis and the treatment.

Studies on Stimulus Responsive Peptides and Their Applications in Tumor Diagnosis and Treatment

Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment

Peptide-Mediated Tumor-Targeted Diagnosis and Therapy

Polypeptides-Based Nanocarriers in Tumor Therapy

Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics

Peptide-Mediated Nano Drug Delivery System for Tumor Targeting

The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides As Drug Delivery Systems Based on Tumor Microenvironment

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics

Peptide-Based Nanomaterials for Tumor Immunotherapy

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

Tumor Microenvironment–Responsive Peptide-Based Supramolecular Drug Delivery System

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment

Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies

Tumor Cell Membrane-Based Peptide Delivery System Targeting to Tumor Microenvironment for Cancer Immunotherapy and Diagnosis

Progress of Stimuli-responsive Nanomaterials in Tumor Analysis

The development of site-specific drug delivery nanocarriers based on receptor mediation.

Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer

Applications of Peptide-based Nanomaterials in Targeting Cancer Therapy

Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

Tacmaa Chemistry-Based Tumor Extracellular Ph-Responsive Polymeric Nanomaterials For Drug Delivery